Non-operative management of rectal cancer
- PMID: 32818013
- PMCID: PMC7431003
- DOI: 10.1053/j.scrs.2019.04.007
Non-operative management of rectal cancer
Abstract
Despite advances in technique, surgical resection of rectal cancer remains a morbid procedure that can lead a profound decrease in a patient's quality of life. A novel method of management, termed "Non-operative management" (NOM), mirrors the management of anal carcinoma. Patients undergo definitive treatment with only chemotherapy and radiation, with resection reserved only for salvage. Current data is encouraging- both in reduction in morbidity and similar, if not superior oncologic results. However, there are a number of barriers to the wide adoption of this practice. This manuscript seeks to describe the rationale and execution of NOM as well as present the current data and pitfalls of the approach.
Keywords: chemotherapy; radiotherapy; rectal cancer; “Non-operative management”; “Watch and wait”.
Conflict of interest statement
Conflicts of Interest: None
Figures
References
-
- Dayal S, Battersby N, Cecil T. Evolution of Surgical Treatment for Rectal Cancer: a Review. J Gastrointest Surg 2017; 21(7):1166–1173. - PubMed
-
- Hawkins AT, Hunt SR. Watch and Wait: Is Surgery Always Necessary for Rectal Cancer? Curr Treat Options Oncol 2016; 17(5):22. - PubMed
-
- Bloemen JG, Visschers RG, Truin W, et al. Long-term quality of life in patients with rectal cancer: association with severe postoperative complications and presence of a stoma. Dis Colon Rectum 2009; 52(7):1251–8. - PubMed
-
- Hupkens BJP, Martens MH, Stoot JH, et al. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study. Dis Colon Rectum 2017; 60(10):1032–1040. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources